Akira Matsuhisa

This inventor holds 11 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Yamanouchi Pharmaceutical Company Ltd., Other. Active years: 1990-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Matsuhisa. Retrieved from https://idiyas.com/inventor/akira-matsuhisa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 90.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Ushiku, JP (2002)
Ibaraki, JP (1990 - 2004)
Tsukuba-shi, Ibaraki, JP (2004)

Company Filing History:

10 out of 329

Yamanouchi Pharmaceutical Company Ltd.

patents

1 out of 834,513

Other

patents

Years Active: 1990-2004

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6734203 - Fused imidazolium derivatives (2004-05-11),

2. 6673799 - Cyanophenyl derivative (2004-01-06),

3. 6340678 - 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them (2002-01-22),

4. 5856564 - Condensed benzazepine derivative and pharmaceutical composition thereof (1999-01-05),

5. 5723606 - Condensed benzazepine derivative and pharmaceutical composition thereof (1998-03-03),

6. 5710150 - Benzazepine derivative, pharmaceutical composition thereof, and (1998-01-20),

7. 5496942 - 5-substituted tetrahydrobenzimidazole compounds (1996-03-05),

8. 5420126 - 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical (1995-05-30),

9. 5344927 - Tetrahydrobenzimidazole derivatives and pharmaceutical compositions (1994-09-06),

10. 5278158 - Oxazinobenzazole compounds (1994-01-11),

11. 4977175 - 4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT.sub.3 -antagonists (1990-12-11),

Title: Akira Matsuhisa: Innovator in Pharmaceutical Chemistry

Introduction

Akira Matsuhisa is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

One of Matsuhisa's latest patents involves fused imidazolium derivatives, specifically a piperazino-substituted novel cyanophenyl derivative. This innovative compound features a substituted carbamoyl or substituted sulfamoyl group that may include an aryl or heterocyclic group. The compound exhibits anti-androgen action, making it useful in preventing or treating prostatic cancer, benign prostatic hyperplasia, and related diseases.

Career Highlights

Throughout his career, Matsuhisa has worked with Yamanouchi Pharmaceutical Company Ltd., where he has played a crucial role in advancing pharmaceutical research and development. His expertise in creating effective therapeutic agents has positioned him as a key figure in the industry.

Collaborations

Matsuhisa has collaborated with notable colleagues, including Isao Yanagisawa and Nobuaki Taniguchi. These partnerships have further enhanced his research capabilities and contributed to the success of his innovative projects.

Conclusion

Akira Matsuhisa's work in pharmaceutical chemistry exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a commitment to developing effective treatments for serious medical conditions.

Profile summary based on public USPTO records.